Survival and hospitalizations with lutetium (Lu)-177 vipivotide tetraxetan in veterans with underlying genomic alterations.

Authors: Sumrah Khan, Vaidehi Panchal, Daniel B. Eaton, Jason M. Doherty, Kara N. Maxwell, Isla Garraway, Matthew Rettig, Ruben Raychaudhuri, Robert Bruce Montgomery, Eric Marshall Knoche, Martin W. Schoen

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5068

Source: Full article

---

Abstract

5068